ForFarmers N.V.

BATS-CHIXE:FFARMA Stock Report

Market Cap: €266.4m

ForFarmers Future Growth

Future criteria checks 3/6

ForFarmers is forecast to grow earnings and revenue by 24.1% and 1% per annum respectively while EPS is expected to grow by 24.3% per annum.

Key information

24.1%

Earnings growth rate

24.3%

EPS growth rate

Food earnings growth8.8%
Revenue growth rate1.0%
Future return on equityn/a
Analyst coverage

Low

Last updated04 May 2023

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:FFARMA - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20253,4233637831
12/31/20243,4193030761
12/31/20233,4162131771
12/31/20223,315181348N/A
9/30/20223,13415742N/A
6/30/20222,95313137N/A
3/31/20222,81212846N/A
12/31/20212,671121555N/A
9/30/20212,58293374N/A
6/30/20212,49455093N/A
3/31/20212,423105696N/A
12/31/20202,352146298N/A
9/30/20202,3572168102N/A
6/30/20202,3612874106N/A
3/31/20202,4122367101N/A
12/31/20192,463185996N/A
9/30/20192,500253171N/A
6/30/20192,53733247N/A
3/31/20192,471462064N/A
12/31/20182,405593882N/A
9/30/20182,3276162101N/A
6/30/20182,2506386120N/A
3/31/20182,2346182118N/A
12/31/20172,2195978116N/A
9/30/20172,184595899N/A
6/30/20172,149593781N/A
3/31/20172,129564281N/A
12/31/20162,109534881N/A
9/30/20162,15252N/A73N/A
6/30/20162,19551N/A65N/A
3/31/20162,22051N/A63N/A
12/31/20152,24451N/A62N/A
9/30/20152,16452N/AN/AN/A
6/30/20152,12554N/AN/AN/A
3/31/20152,17351N/AN/AN/A
12/31/20142,22148N/A79N/A
9/30/20142,30341N/AN/AN/A
6/30/20142,42634N/AN/AN/A
3/31/20142,49133N/AN/AN/A
12/31/20132,47231N/A55N/A
12/31/20126,56253N/A48N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: FFARMA's forecast earnings growth (24.1% per year) is above the savings rate (1.2%).

Earnings vs Market: FFARMA's earnings (24.1% per year) are forecast to grow faster than the UK market (10.3% per year).

High Growth Earnings: FFARMA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: FFARMA's revenue (1% per year) is forecast to grow slower than the UK market (4% per year).

High Growth Revenue: FFARMA's revenue (1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if FFARMA's Return on Equity is forecast to be high in 3 years time


Discover growth companies